News
-
-
-
Fosun International’s HSI ESG rating upgraded, Selected as constituent of Hang Seng Corporate Sustainability Benchmark Index
2020-09-07
-
-
-
-
Fosun International improves MSCI ESG rating to grade A
2020-09-03
-
-
-
-
Fosun International Announces 2020 Interim Results Total revenue reaches RMB63.27 billion, demonstrating a rapid business recovery
2020-08-27
-
-
-
-
China’s First Trastuzumab Biosimilar 汉曲优® Approved by NMPA
2020-08-14
-
-
-
-
Fosun International improves MSCI ESG rating to grade A
2020-08-13
Fosun International’s MSCI ESG rating has improved from BBB last year to A in 2020.
-
-
-
-
Peak Re named “Asian Reinsurer of the Year” for the fifth consecutive time
2020-08-07
-
-
-
-
Wolves brand named in football's top 20
2020-08-07
-
-
-
-
Challenge Dilemmas in The Treatment of SCCHN, Henlius Innovative Combination Therapy Dosed The First Patient in A Phase 2 Clinical Trial
2020-07-30
-
-
-
-
Guo Guangchang: The First Dose! The novel coronavirus mRNA vaccine has officially started the human clinical trial in China
2020-07-29
-
